Clinical Trials · NCT01169779
Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Sanofi
- Enrollment
- 391
- Start date
- Jul 2010
- Locations
- 35 sites, 4 countries
- Primary endpoint
- Absolute Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 24